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Abstract 
Bipolar disorder is a multifactorial illness with uncertain aetiology. Knowledge of 
potential risk factors enables clinicians to identify patients who are more likely to 
develop bipolar disorder, which directs further investigation, follow up and caution when 
prescribing. Ideally, identifying directly causative factors for bipolar disorder would 
enable intervention on an individual or population level to prevent the development of the 
illness, and improve outcomes through earlier treatment. This article reviews the 
epidemiology of bipolar disorder, along with putative demographic, genetic and 
environmental risk factors, while assessing the strength of these associations and to what 
extent they might be said to be “causative”. While numerous genetic and environmental 
risk factors have been identified, the attributable risk of individual factors is often small, 
and most are not specific to bipolar disorder but are associated with several mental 
illnesses. Therefore, while some genetic and environmental factors have strong evidence 
supporting their association with bipolar disorder, fewer have sufficient evidence to 
establish causality. There is increasing interest in the role of specific gene-environment 
interactions as well as the mechanisms by which risk factors interact to lead to bipolar 
disorder.  
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Introduction 
Bipolar Affective Disorder (bipolar) is a multi-component illness involving 
episodes of severe mood disturbance, neuropsychological deficits, immunological and 
physiological changes and disturbances in functioning1. It is one of the leading causes of 
disability worldwide2 and is associated with high rates of premature mortality from both 
suicide and medical comorbidities3, 4.  
The aetiology of bipolar is not well understood and research into the disorder lags 
behind disorders such as psychosis. However, the last decade has seen an expanding 
evidence into the genetics of the disorder, underlying developmental pathways, risks and 
vulnerability factors, gene-environment interactions and the putative features of the 
bipolar prodrome.  
This article summarises the research into demographic, genetic and environmental 
risk factors for the development of bipolar, with a focus on recent updates and the role of 
environmental triggers. To identify relevant literature, searches were conducted in 
PubMed and PsycINFO using the terms Bipolar Disorder, combined with risk factors or 
epidemiology. Results were reviewed with a focus on the most recent evidence and 
systematic reviews or large prospective studies, and further individual searches were then 
expanded for each risk factor category identified. A summary of the included studies 
relating to specific risk factors for bipolar are included in Table 1.  
Epidemiology of bipolar disorder 
Epidemiological studies have suggested a lifetime prevalence of around 1% for 
bipolar type I in the general population5, 6. A large cross-sectional survey of 11 countries 
found the overall lifetime prevalence of bipolar spectrum disorders was 2.4%, with a 
prevalence of 0.6% for bipolar type I and 0.4% for bipolar type II7. Although findings 
varied across different countries, this suggested a lower prevalence of bipolar type I and 
II than previous studies6, 8, while the prevalence of bipolar type I in USA was found to be 
1%, slightly higher than the other countries. It is unclear whether differences were due to 
more stringent diagnostic criteria used in this study, or true differences in rates of bipolar 
across countries and ethnic groups. In one of the very few epidemiological investigations 
in England the recent Adult Psychiatric Morbidity Survey 2014 found lifetime prevalence 
of likely bipolar was 2%. The measurement method suggests that this was an 
underestimate, but the study did not distinguish bipolar subtypes9. A recent meta-analysis 
of 25 studies found a pooled lifetime prevalence of 1.06% and 1.57% for bipolar type I 
and II respectively, although the majority of the included studies were from North or 
South America10. Nevertheless, a similar prevalence has been found in the UK, Germany 
and Italy11, and a lifetime prevalence between 0.1-1.83% was found in a systematic 
review of studies from African countries12.  
The reason for international variations in the prevalence of bipolar is not entirely 
clear, and ethnicity13, cultural factors14 and variations in diagnostic criteria and study 
methodology10 may each have an impact. The evidence for differing rates of bipolar in 
different ethnicities is conflicting, with some studies showing higher rates in 
Caucasians15, 16 and others in non-white populations17. A systematic review found no 
clear evidence for differences across ethnic groups, and suggested individual study 
differences may be related to cultural factors, migration and higher rates of misdiagnosis 
of black ethnic groups as having schizophrenia rather than bipolar13. With regards to 
gender, several studies report equal distribution in bipolar13, while others have identified 
a higher prevalence of manic episodes and bipolar type I in males and higher rates of 
bipolar type II in females7. Overall, the evidence is not sufficiently strong to deviate from 
the view that bipolar appears to have a roughly equal distribution across gender and 
ethnicity.  
The mean age of onset for bipolar appears to be in the early twenties7, although 
findings vary between 20-30 years6. A bimodal distribution of the incidence of bipolar 
has been suggested18, supported by a large population based cohort study, which found 
two peaks in age of onset at 15-24 years and at 45-54 years19. However, age of onset 
estimates are very difficult to define accurately for bipolar given the long periods of 
untreated illness, when symptoms can be nascent or apparent without individuals 
accessing services, which is often used at the measure of onset in many studies20. 
Moreover, there appear to be differences in the presentation and clinical course of bipolar 
depending on age of onset21, with higher rates of psychiatric and medical comorbidities 
such as suicidality and vascular disease in later onset mania22.  
A number of studies have investigated rates of bipolar according to 
sociodemographic variables, with generally inconsistent findings13. There is some 
evidence of higher rates in low income, unemployed and unmarried groups13, although 
the social disruption caused by severe mental illness giving rise to such associations 
cannot be ruled out5. Conversely, an interesting finding among some studies is that higher 
socioeconomic status and higher occupational level as well as creativity5, 23 are associated 
with increased risk of bipolar24, 25, which is opposite to that of unipolar depression and 
schizophrenia5. However, these studies are limited by small sample sizes and a lack of 
replication26. Explanations for this association include the possibility of referral bias for 
those with higher socioeconomic status, while some have suggested that those with high 
functioning creative traits may confer a genetic risk of bipolar5.  
There is also emerging evidence for an association between urban environments 
and increased rates of bipolar13. While the evidence is stronger for schizophrenia, where 
there have been multiple suggested explanations27, the reason for the association between 
urbanisation and bipolar is less clear. However, a cohort study found that there was a 
strong association between urban residence and the incidence of psychotic bipolar, but no 
association for bipolar without psychosis28. This may suggest that urban residence is a 
trans-diagnostic risk factor for psychotic illness rather than bipolar per se.  
Genetics and gene environment interactions  
The contribution of genetic factors to bipolar has long been identified, with 
evidence from twin studies suggesting mono-zygotic concordance of between 40-70%, 
and lifetime risk in first-degree relatives is 5-10%; around 7 times higher than the general 
population risk29. However, relatives of patients with bipolar are more likely to develop 
unipolar depression than bipolar themselves, suggesting the genetic risk transcends 
diagnostic categories29. There is also evidence of shared genetic risk between bipolar, 
schizophrenia and autism30, 31. Nonetheless, bipolar clearly does not follow a Mendelian 
pattern of inheritance, and linkage studies have not identified individual genes with a 
strong association with the disorder32. The genetic risk for bipolar in part is likely due to 
multiple single nucleotide polymorphisms, which are highly prevalent in the general 
population and confer a very small increased risk individually33. Technological advances 
have allowed for genome wide association studies which have pooled data and identified 
multiple genetic loci associated with bipolar patients suggesting aggregated polygenic 
risk34.  
Whilst many important genetic loci have been identified, how these translate to 
risk of illness is a second frontier of discovery. Studies have identified polymorphisms in 
genes coding for brain derived neurotrophic factor (BDNF) to be associated with 
bipolar35. BDNF is suspected to be involved in the pathogenesis of bipolar as well as a 
potential biomarker of disease activity36. Associations with catechol-O-methyl transferase 
(COMT) and monoamine transporters have also been observed37, 38. Genes for voltage 
gated calcium channel subunits such as CACNA1C are located near to single nucleotide 
polymorphisms that have an association with bipolar, as well as proteins involved in cell 
signalling such as ODZ434, and genes encoding for GABA receptor subunits39. The fact 
that many of the medications used as prophylactic agents in bipolar act on calcium 
channels or GABA receptors40 suggests these proteins may be involved in the 
neurobiology of the disorder, and this evidence is guiding the search for new therapeutic 
targets41.  
However, it is clear that the effect size of each single nucleotide polymorphism is 
very small. For example, the odds of having bipolar in those with the polymorphism 
around CACNA1C is 1.14, and the majority of those with this polymorphism do not go 
on to develop the disorder33, 34. There has therefore been increasing interest in the role of 
how gene-environment interactions contribute to the onset of bipolar, although this 
remains an under researched area compared to schizophrenia42, 43. Nevertheless, 
interaction between childhood abuse and BDNF gene polymorphisms have been shown 
in several studies42, 44, while toll-like receptor 2 polymorphisms may interact with 
stressful life events and Toxoplasma gondii infection to increase the risk of bipolar45, 46. A 
COMT polymorphism has been found to interact with stressful life events for bipolar 
depressive episodes47, while serotonin transporter genes have interactions with cannabis 
use on the presence of psychotic symptoms in bipolar48. With the increasing ability of 
genome wide association studies to identify polymorphisms conferring a very small 
increased risk, further study of how these genes interact with environmental factors to 
trigger bipolar is required.  
Environmental risk factors  
Prenatal and perinatal factors  
Prenatal viral infections have been implicated in a number of mental illnesses, 
including bipolar49-51. A recent review by Barichello et al52 investigated associations 
between bipolar and 10 infectious agents. Findings between studies were generally 
inconsistent, and no association was found for Epstein-Barr virus, human herpesvirus 6 or 
varicella zoster virus. Five of the eleven studies investigating cytomegalovirus found an 
association between antibody levels and bipolar, while two studies found an association 
between maternal influenza infection and bipolar with psychosis53, 54, although other 
studies found no association55-57.  None of these studies were prospective or longitudinal 
and it is uncertain whether these infections occurred during pregnancy or subsequently. 
Therefore the evidence for maternal viral infection as a risk factor for bipolar remains 
weak overall. 
However, there is stronger evidence for an association between bipolar and 
seropositivity for Toxoplasma gondii infection, demonstrated in two recent meta-
analyses58, 59. The first included 11 studies and demonstrated overall increased odds of 
having bipolar in those with immunoglobulin G (IgG) to T. gondii, with an odds ratio of 
1.52 (95% confidence interval 1.06-2.18)58. A second meta-analysis of 8 studies also 
found a significant association between bipolar and T. gondii seropositivity with an odds 
ratio of 1.26 (95% confidence interval 1.08-1.47)59. However, the included studies were 
not prospective and it remains uncertain when T. gondii exposure occurred. 
Notwithstanding, there is preclinical evidence suggestive of a relationship between T. 
gondii and development of mental illness, with studies showing behavioural changes in 
mice60 and humans61, 62. Moreover, there is evidence that infection with T. gondii causes 
changes in dopamine metabolism leading to increased dopamine production63, similar to 
that suggested as a potential mechanism for manic episodes in bipolar64. Furthermore, 
there is evidence that following T. gondii infection the local inflammatory response leads 
to alteration in cytokines65, such as IL-666 which have been implicated in mental illness 
and bipolar specifically67, 68, and may be related to cognitive deterioration in this patient 
group66.  
Evidence regarding other prenatal exposures such as maternal smoking and severe 
psychological stressors are inconsistent, with only a small number of studies investigating 
these factors69. Obstetric complications have generated interest as a risk factor for later 
development of bipolar70, but a meta-analysis found no significant evidence for this 
association71, and bipolar patients were less likely to have experienced obstetric 
complications than those with schizophrenia. A systematic review by Marangoni et al69 
identified prospective studies which suggested extreme prematurity (less than 32 weeks 
gestation) conferred a significant risk of developing bipolar.  
In general, the evidence for prenatal and perinatal factors as an independent risk 
factor for developing bipolar is relatively weak and inconsistent, and such factors appear 
to confer greater risk for developing other mental disorders, such as schizophrenia71. The 
evidence for T.gondii infection is more substantial, while maternal CMV and influenza 
infection warrant further investigation as to their associations with bipolar.  
Postnatal factors 
Childhood maltreatment  
Childhood maltreatment is a well-studied environmental risk factor with high 
quality evidence that it confers a risk for later development of bipolar72, although it is 
also associated with behavioural problems and other mental illnesses73, 74. When 
investigating specific subtypes of abuse, several studies have identified a link between 
emotional abuse or emotional neglect and the later the development of bipolar75, 76 while 
emotional abuse appears to be the most frequent subtype of abuse experienced in bipolar 
patients77. A recent high quality meta-analysis of childhood adversity in bipolar patients 
compared to healthy controls found significant associations between development of 
bipolar and prior physical, sexual and emotional abuse and physical and emotional 
neglect78. The largest association was for emotional abuse which was four times more 
likely to have occurred in bipolar patients than controls78. Moreover, higher rates of 
childhood adversity were found in patients with bipolar compared to unipolar depression, 
although similar rates to schizophrenia78. Gilman et al79 also found that a history of 
childhood abuse increased the risk of transitioning to bipolar following a depressive 
episode. This suggests that abuse and neglect during childhood confer some specific risk 
to more severe forms of mental illness.  
As well a risk factor, childhood maltreatment appears to be associated with poorer 
clinical outcomes in bipolar, with more severe and more frequent mood episodes80, 
earlier onset, increased risk of suicide and comorbid substance misuse81. The relationship 
between childhood abuse and the severity of bipolar adds further weight to its position as 
potential causative factor for the disorder. Notwithstanding, childhood maltreatment does 
not appear to be specifically related to psychotic symptoms or a diagnosis of bipolar type 
I over type II78, 82.  
Whilst it seems likely that childhood traumatic events increase the risk of bipolar, 
why or how they do this remains unclear but is the focus of ongoing research. Traumatic 
events are linked to increased levels of affective instability or emotional dysregulation 
more generally in people with bipolar and this represents one possible mechanism of 
action83. Other dimensions of psychopathology such as hostility and impulsivity, along 
with affective instability have been shown to mediate the association between childhood 
maltreatment and outcomes in bipolar84, while alterations in the hypothalamic-pituitary-
adrenal (HPA) axis85, increased levels of BDNF and inflammatory cytokines86 and 
reduced limbic grey matter volume87 represent possible neurobiological underpinnings of 
the effect of childhood trauma and how this may lead to later psychopathology and 
bipolar in particular. 
It should be noted that there is difficulty in determining to what extent childhood 
maltreatment is a cause or consequence of the predisposition to develop bipolar, as 
parental psychopathology may confer a genetic risk of the disorder as well as increased 
risk of childhood maltreatment88. The retrospective nature of these studies introduces the 
possibility of recall bias with regard to childhood adversity, and at present there are few 
prospective studies investigating the association between childhood maltreatment and 
bipolar. 
Psychological stressors  
Recent stressful life events are known to affect the course of bipolar89, although 
their relationship with the onset of the disorder has been less extensively investigated 
compared to unipolar depression13. A systematic review by Tsuchiya et al13 identified 
four studies investigating stressful life events prior to the onset of bipolar, the three 
largest of which found an increased risk of onset within 6 months of such events. A meta-
analysis found that patients experience more life events prior to relapses into either manic 
or depressive episodes than during euthymic periods, although the rate of significant life 
events prior to the onset of bipolar was similar to unipolar depression90. Other studies 
have supported the association between life events and the onset of bipolar, including a 
large case control study which found that stressful life events were associated with a first 
hospitalisation for a manic episode, particularly suicide of a first-degree relative, but also 
recent marriage, divorce, disability or unemployment91. There are a number of 
confounders to these associations, particularly with regard to suicide of a first degree 
relative where genetic factors play a significant role, as death due to other causes was not 
associated with hospitalisation91. A bi-directional relationship has also been suggested for 
stressful life events in bipolar as there is evidence that these events occur both prior to 
and following mood episodes92.  
There is also evidence for specific life events conferring a risk for bipolar, such as 
early parental loss and childbirth. The systematic review by Tsuchiya et al13 found that 
only 3 of the 10 studies investigating parental loss identified an association with bipolar, 
although it is noteworthy that one of these was a very large cohort study which adjusted 
for a number of confounders, including family history of mental illness93. A meta-
analysis found that childbirth specifically increased the risk of mood episodes in patients 
with bipolar, more so than relapses in unipolar depression or schizophrenia90. Tsuchiya et 
al13 identified only 3 studies investigating onset of bipolar following childbirth, but each 
found an association with subsequent bipolar diagnosis within 12 months. This is perhaps 
unsurprising considering the association between puerperal psychosis and bipolar94, but it 
is unclear whether the reason for the association is genetic, hormonal or related to 
childbirth as a life event.  
However, life events are relatively non-specific in relation to mental and physical 
illness, and appear to be associated not only with the onset of bipolar disorder and 
unipolar depression, but also psychosis95, anxiety disorders96, ischaemic stroke97 and 
circulatory disorders98. While gene-environment interactions have been identified 
between life events and the onset of specific disorders47, the use of checklists to identify 
life events in such studies has been criticised as lacking sufficient detail with regard to 
the severity and context of such events99. These methodological issues make it difficult to 
establish causation between life events and development of bipolar.    
Substance misuse  
Bipolar is frequently comorbid with misuse of substances, including cannabis, 
opioids, cocaine, sedatives and alcohol69, 79, and causality has been suggested in both 
directions100. While the high level of comorbidity is undeniable, causality it much harder 
to ascertain as there is often difficulty is establishing the temporal relationship between 
substance misuse and the onset of mental illness. This is compounded by the relative lack 
of prospective, longitudinal studies examining the relationship between substance misuse 
and bipolar101.   
There is increasing evidence that cannabis use can act as a risk factor for the 
development of bipolar as well as psychotic disorders. A recent systematic review by 
Gibbs et al102 identified several studies supporting a link between cannabis use and 
subsequent relapse of manic symptoms. This review also included a meta-analysis of two 
large prospective cohort studies103, 104 which found that cannabis use almost trebled the 
risk of new onset subthreshold manic symptoms after adjusting for potential confounding 
factors.  A further large prospective cohort study found cannabis use increased the risk of 
first episode bipolar by a factor of 5 after adjusting for confounders, and demonstrated 
evidence of a dose response relationship105. Other studies were more equivocal, finding 
increased risk of bipolar only in those with weekly to daily cannabis use and no dose 
response relationship106, or increased risk only in those with a past year episode of 
depression79. Recently a prospective analysis has demonstrated cannabis use at age 17 is 
associated with hypomania in young adulthood independent of psychotic symptoms and 
other important confounders. Further path analysis indicated cannabis use is one 
mechanism by which childhood abuse translates to increased risk of bipolar symptoms107.  
Other substances of abuse are also important in the risk of bipolar. Prospective 
studies have linked opioid use to an increased risk of developing bipolar, which is greater 
than other mood disorders108, 109. A further study found that alcohol and drug abuse or 
dependence before the age of 25 increased the odds of developing subsequent bipolar, 
although differences between specific drugs were not examined110. Cocaine use has also 
been implicated although is less well studied111, and as stimulant use can precipitate 
mania or similar symptoms100 this may lead to inappropriate diagnosis of bipolar112, 
rather than act as a causative factor.  
There are significant confounding factors to associations between bipolar and 
substance misuse, which remain despite attempts at adjustment within the studies. It has 
been suggested that cannabis may help to self-medicate for bipolar illness113, and 
therefore may be used by those with subthreshold symptoms prior to the onset of bipolar. 
Furthermore, there is evidence that shared genetic factors confer risk to develop both 
substance misuse disorders and bipolar114, 115, while childhood maltreatment is also 
associated with both disorders77, 80, 88.  
Medical comorbidity 
Bipolar is known to be comorbid with a number of medical and psychiatric 
conditions72, 116, 117. There are multiple reasons for this, including shared genetic and 
environmental vulnerabilities, consequences of treatment, recognition bias on the part of 
clinicians as well as the potential for a direct causal relationship in either direction.   
There is strong evidence for the association between bipolar and irritable bowel 
syndrome (IBS)72 highlighted in a recent large meta-analysis of retrospective cohort 
studies118. However, potentially important confounders such as antidepressant use were 
not adjusted for. There is also evidence that both disorders may share inflammatory72, 119, 
120 and stress related aetiologies90, 121, which could give rise to this association.  
Similarly, recent meta-analyses have shown asthma122, obesity 123, migraine124 
and head injury125 are associated with bipolar. The evidence for these associations is 
mediated by the relatively small number of studies included, most of which were cross 
sectional and lacked data to adjust for confounding factors. However, for asthma a 
retrospective cohort126 and large prospective study127 also support the association, which 
may be mediated by shared inflammatory pathways119, 120 or the use of corticosteroids 
during early childhood116, 126. Medication and lifestyle factors significantly confound the 
association with obesity, for which there are few prospective studies and weak evidence 
for a directly causal relationship, while the association with traumatic brain injury is 
potentially confounded by ‘accident-proneness’ or physical abuse128. There is evidence of 
increased prevalence of bipolar in patients with multiple sclerosis (MS)129, 130 which 
cannot be completely accounted for by steroid induced mania, and in some instances 
psychiatric symptoms may predate the diagnosis of MS131. However, other studies have 
not supported this association116.  
A meta-analysis reported high lifetime prevalence of anxiety disorders in bipolar 
patients132, while ADHD, conduct disorders, aggression and impulsivity also appeared to 
increase risk of developing bipolar117.  
Prodromal features and bipolar at-risk criteria 
It is becoming increasingly recognised that bipolar, like schizophrenia, has a 
prodromal phase which can be identified prior to development of the full illness133, 134. 
However, one issue with research into this area is the potential conflation of the concepts 
of a prodrome for bipolar, referring to symptoms that can be retrospectively identified as 
preceding the onset of the disorder, and a ‘risk syndrome’ consisting of clinical features, 
comorbidities and risk factors which increase the risk of later developing bipolar135. At 
present neither prodrome nor risk syndrome has been fully defined, although the bipolar 
at-risk (BAR) assessment tool has demonstrated predictive validity and reliability for 
identifying those at risk of bipolar, with around 23% of those identified transitioning to 
mania or hypomania136. A study using the BAR assessment tool criteria found that 
cyclothymia had the best overall clinical utility for case finding and screening when 
focussing on depressed youths with an early transition to bipolar. The clinical utility 
profile of sub-threshold mania, anti-depressant emergent elation, family history of bipolar 
and atypical depression suggested they were better for screening out non-cases137. 
However, other studies have questioned the associations between clinical characteristics 
of depression and transition to bipolar79.  
The low positive predictive value of these precursors reduces their usefulness, and 
of the significant proportion of those ‘at risk’ who do not go on to develop bipolar there 
is limited understanding of what factors are protective against this transition, or how this 
group differs from those who do develop bipolar135. Future research should focus on 
identifying differences in this group, while continuing to refine screening tools for 
prodromal identification and risk syndromes in prospective studies. Focussing on 
transition to first episode mania may have greater reliability in identifying cases135.  
First episode bipolar mania has an annual incidence of around 5 per 100,000 of 
population138, and peak incidence occurs between 21-25 years139. Although the incidence 
of first episode mania is equal between males and females138, studies have found that age 
of onset is around 5 years earlier for men140. A meta-analysis of longitudinal studies of 
first episode mania found that 87.5% of patients achieve syndromal recovery within the 
first year, meaning they no longer meet criteria for diagnosis. However, the symptomatic 
recovery rates (essentially defined as being symptom free) were 62.1% within the first 
year, while 41% experience a recurrence of a manic, mixed or depressed episode over the 
same period141. Considering the relatively poor outcome in such patients, the potential to 
identify a risk syndrome or prodromal phase of bipolar in those presenting with a 
depressive illness offers the opportunity intervene at an earlier stage, leading to improved 
outcomes20.  
Conclusions 
Risk factors for bipolar are numerous, both genetic and environmental, but low 
attributable risk, inconsistency of results, inability to identify the temporality of the 
relationship, lack of a clear biological mechanism and the non-specific nature of many 
risk factors means that causation is difficult to assign in an individual patient. Studies of 
environmental risk were also unable to completely adjust for confounding. However, 
there is evidence that severity of bipolar is related to childhood emotional abuse and the 
degree of cannabis misuse, suggesting a dose-response relationship. The association with 
Toxoplasma gondii is also strong with some evidence of biological plausibility, although 
concerns remain about temporality. Bipolar is associated with medical comorbidities such 
as IBS and asthma, which may point towards shared inflammatory pathophysiology of 
the disorders, while other psychiatric disorders and clinical features that predate the onset 
of bipolar may point towards an identifiable ‘risk syndrome’. Future research into these 
risk factors should focus on establishing temporality, whether the severity of bipolar is 
linked to the risk factor, and identifying potential neurobiological and environmental 
mechanisms to explain the associations. Finally, research into gene-environment 
interactions is required to link existing evidence on genetic and environmental risks.  
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Table 1: Studies investigating specific risk factors for bipolar disorder 
Study Risk factor examined Design N 
(participants / 
studies) 




Familial genetic risk  Review 8 studies Meta-analysis provided an overall estimate of the risk of 
bipolar in first degree relatives of bipolar type I probands OR=7 
(95% CI 5-10) 
6 studies 
 
Pooled data provided an estimate of probandwise monozygotic 













Genome-wide significant evidence of association for rs4765913 
in CACNA1C (P=1.52 × 10−8, OR=1.14) and rs12576775 in 
ODZ4 (P=4.40 × 10−8, OR=0.89) 
Fan and Sklar 
200835 
BDNF Val66Met polymorphism Meta-analysis  14 studies Meta-analysis shows evidence for the association between 
Val66Met polymorphism in BDNF and bipolar (OR=1.13, 95% 
CI 1.04-1.23, P=0.004) 
Cho et al 200538 5-HTTL polymorphic region and 
intron 2 variable numbers of 
tandem repeats polymorphisms 
Meta-analysis 17 studies The review revealed significant pooled OR=1.12 (95% CI 1.03-
1.21) for the association between bipolar and 5-HTTL 
polymorphic region and OR=1.12 (95% CI 1.02–1.22) for the 
intron 2 variable numbers of tandem repeats polymorphisms 
Aas et al 201444 Gene-environment interaction of 






There was an additive effect between a history of childhood 
trauma and BDNF val66met, with met carriers with high levels 
of childhood trauma having the lowest BDNF mRNA levels. 
Oliveira et al 
201545 
Gene-environment interaction of 






A combined effect of TLR2 rs3804099 TT genotype and 
reported sexual abuse was observed on determining an earlier 
age at onset of bipolar (corrected P=0.02) 
Oliveira et al 
201646 
Gene-environment interaction of 
TLR2 genetic variation and 
Toxoplasma gondii exposure  





There was a trend for an interaction between the TLR2 
rs3804099 SNP and Toxoplasma gondii seropositivity in 
conferring bipolar risk (P=0.017, uncorrected) 
Hosang et al 
201747 
Gene-environment interaction of 
COMT Val158 Met polymorphism 
and stressful life events 
Case-control 482 bipolar 
patients 
 
The impact of stressful life events was moderated by the 
COMT genotype for the worst depressive episode using a Val 
205 healthy 
controls 
dominant model (adjusted risk difference 0.09, 95% CI 0.003-
0.18, p=0.04) 
De Pradier et al 
201048 
Gene-environment interaction of 
serotonin transporter gene 
polymorphism, cannabis and 
childhood sexual abuse  
Case-control 137 bipolar 
patients 
The short allele of the 5-HTTLPR polymorphism and cannabis 
abuse were significantly more frequent among patients with 
psychotic symptoms than in those without (p=0.01 and 
p=0.004, respectively), while childhood sexual abuse was not 
Prenatal and perinatal factors 
Barichello et al 
201652 
Perinatal infections Systematic 
Review 
23 studies Studies investigated exposure to several pathogens namely 
Cytomegalovirus, Epstein–Barr Virus, Herpes simplex virus-1, 
Herpes simplex virus-2, Human herpesvirus 6, Toxoplasma 
gondii, Influenza, and Varicella zoster virus. Overall, studies 
provided mixed evidences. 
Sutterland et al 
201558 
T. gondii Meta-analysis 11 studies Significant association of T. gondii infection with bipolar, 
OR=1.52 (95% CI 1.06–2.18, P=0.02) 
De Barros et al 
201759 
T. gondii Meta-analysis 8 studies T. gondii infection is associated with bipolar (OR=1.26, 95% 
CI 1.08-1.47) 
Scott et al 200671 Obstetric complications Meta-analysis 8 studies The pooled OR for the exposure to obstetric complications 
on subsequent development of bipolar was 1.15 (95% CI 0.62–
2.14).   
Childhood trauma 
Watson et al 
201475 




Significantly higher rates of childhood trauma were observed in 
patients with bipolar compared to controls. Logistic regression, 
controlling for age and sex, identified emotional neglect to be 
the only significant childhood trauma questionnaire subscale 
associated with bipolar. 
Etain et al 201076 Childhood trauma Case-control 260 bipolar 
patients 
 
94 controls  
The Childhood Trauma Questionnaire total score was higher for 
bipolar than controls. The presence of multiple trauma was 
significantly more frequent in bipolar than controls (63% vs. 
33%). Multiple logistic regression suggested that only 
emotional abuse was associated with bipolar with a suggestive 
dose-effect. 




Histories of severe childhood abuse were identified in about 
half of the sample and were associated with early age at illness 
onset. Abuse subcategories were strongly inter-related. Multiple 
forms of abuse showed a graded increase in risk for both 
suicide attempts and rapid cycling. 
Palmier-Claus et al 
201678 
Childhood trauma Meta-analysis 19 studies Childhood adversity was 2.63 times (95% CI 2.00–3.47) more 
likely to have occurred in bipolar compared with non-clinical 
controls. The effect of emotional abuse was particularly robust 
(OR=4.04, 95% CI 3.12–5.22) 
Agnew-Blais and 
Danese 201680 
Childhood trauma and outcomes 
in bipolar 
Meta-analysis 30 studies Patients with bipolar and history of childhood maltreatment had 
greater severity of mania, depression and psychosis, higher risk 
of comorbidity, earlier age of onset, higher risk of rapid 
cycling, greater number of manic or depressive episodes, and 
higher risk of suicide attempt compared with those with bipolar 
without childhood maltreatment. 
Daruy-Filho et al 
201181 




19 studies Childhood maltreatment predicted worsening clinical course of 
bipolar. Childhood maltreatment can be strongly associated to 
early onset of disorder, suicidality, and substance abuse 
disorder in patients with bipolar. 
Upthegrove et al 
201582 






There was no relationship between childhood events or abuse 
and psychosis. Childhood events were not associated with an 
increased risk of persecutory or other delusions. Significant 
associations were found between childhood abuse and auditory 
hallucinations, strongest between sexual abuse and mood 
congruent or abusive voices.  
Psychological stressors 
Lex et al 201790 Life events prior to relapse Meta-analysis 42 studies Patients with bipolar reported more life events before relapse 
compared to euthymic phases. They also experienced more life 
events relative to healthy individuals and to physically ill 
patients. No significant difference in the number of life events 
was found comparing bipolar to unipolar depression and 
schizophrenia. 
Kessing et al 
200491 
Life events and first admission for 
mania 





Suicide of a mother or of a sibling was associated with 
increased risk of first psychiatric admission with mania/mixed 
episode. Death of a relative by other causes was not associated 
with increased risk of admission. Recent unemployment, 
divorce, or marriage also showed moderate effects.  
Koenders et al 
201492 




Negative life events were significantly associated with 
subsequent severity of mania and depressive symptoms and 
functional impairment, whereas positive life events only 
preceded functional impairment due to manic symptoms and 
mania severity. For the opposite temporal direction mania 
symptoms preceded the occurrence of positive life events and 
depressive symptoms preceded negative life events. 
Substance misuse 
Gibbs et al 2015102 Cannabis Meta-analysis 6 studies (2 in 
meta-analysis) 
Studies support an association between cannabis use and the 
exacerbation of manic symptoms in those with previously 
diagnosed bipolar. Furthermore, a meta-analysis of two studies 
suggests that cannabis use is associated with an approximately 
3-fold (OR=2.97, 95% CI 1.80–4.90) increased risk for the new 
onset of manic symptoms. 






Use of cannabis at baseline increased the risk for manic 
symptoms during follow-up (adjusted OR=2.70, 95% CI 1.54-
4.75), adjusted for age, sex, educational level, ethnicity, marital 
status, neuroticism, use of other drugs, use of alcohol, 
depressive symptoms and manic symptoms at baseline. 






Onset of manic symptoms was associated with cannabis use 
(OR=4.26, 95% CI 1.42, 12.76; P<0.01)  






After adjustment for strong confounders, any use of cannabis at 
baseline predicted an increase in the risk of first bipolar episode 
(OR=4.98; 95% CI 1.80–13.81) 







Weekly to almost daily cannabis use was associated with 
increased incidence of bipolar (adjusted OR for weekly to daily 
use=2.47, 95% CI 1.03–5.92); daily use was not (adjusted 
OR=0.52, 95% CI 0.17–1.55) 






Cannabis use at least 2–3 times weekly was associated with 
later hypomania (OR=2.21, 95% CI 1.49–3.28) after 
adjustment. There was a dose-response relationship (any use vs 
weekly). Cannabis use mediated the association of both 
childhood sexual abuse and hypomania, and male gender and 
hypomania.  
Schepis and Hakes 
2011108 
Opioids, tranquilizers, stimulants 






Life-time and past year non-medical use of prescription 
medications (NUPM) increased risk for new onset of 
psychopathology with particular risk for non-NUPM substance 
use and bipolar. 
Schepis and Hakes 
2013109 
Opioids, tranquilizers, stimulants 






Incidence of bipolar was related to opioid non-medical use of 
prescription medications (NUPM) evidenced in a stepwise risk 
progression based on the NUPM frequency. 
Kenneson et al 
2013110 




Substance dependence was associated with higher odds of 
mood disorders than was abuse. Among the specific mood 
disorders, the increased odds of developing bipolar were 









Subjects reporting cocaine use during follow up were 5.5 
times more likely to experience the mania syndrome (P=0.006).  
Medical comorbidities 




There were significantly increased rates of several medical 
illnesses in bipolar. A high medical illness burden was 
associated with a history of anxiety disorder, rapid cycling, 
suicide attempts and mood episodes with a typically acute 
onset. 
Faedda et al 
2014117 
Clinical risk factors Systematic 
review 
16 studies Despite heterogeneity in methods, findings across studies were 
consistent. Clinical risk factors of bipolar were early-onset 
panic attacks and disorder, separation anxiety and generalized 
anxiety disorders, conduct symptoms and disorder, ADHD, 
impulsivity and criminal behaviour. 
Tseng et al 2016118 Irritable bowel syndrome (IBS) Meta-analysis 6 studies The prevalence rate of bipolar was significantly higher in the 
IBS patients than in the controls (OR=2.48, 95% CI 2.35-2.61, 
P < 0.001). 
Wu et al 2016122 Asthma Meta-analysis 4 studies There were significantly higher prevalence rates of bipolar in 
asthmatic patients than in healthy controls (OR=2.12, 95% CI 
1.57–2.87, P < 0.001) 
Zhao et al 2016123 Obesity Meta-analysis 9 studies Meta-analysis suggests that obesity is associated with increased 
prevalence of bipolar (OR=1.77, 95% CI: 1.40-2.23, P<0.001) 
Fornaro and 
Stubbs 2015124 
Migraine Meta-analysis 14 studies The overall pooled prevalence of migraine in bipolar was 
34.8% (95% CI 25.54-44.69). 
Perry et al 2016125 Traumatic Brain Injury Meta-analysis 3 studies A random effects meta-analysis revealed a significant 
association of prior TBI with subsequent neurologic and 








Participants who had a history of asthma that lasted six months 
or more were at higher risk of panic disorder, obsessive 
compulsive disorder, posttraumatic stress disorder, bipolar, 
mania and hypomania. 





The atopic cohort had an increased risk of developing bipolar 
(HR 2.51, 95% CI 1.71-3.67) compared to the non-atopic 
cohort 




Compared to controls, MS patients had a higher lifetime 
prevalence of MDD (P<0.0001), bipolar type I (P=0.05), 
bipolar II (P<0.0001) and Cyclothymia (P=0.0001) 
Nabavi et al 
2015132 
Anxiety disorders Meta-analysis 52 studies The rate of lifetime comorbidity was as follows: panic disorder 
16.8% (95% CI 13.7–20.1), generalised anxiety disorder 14.4% 
(95% CI 10.8–18.3), social anxiety disorder 13.3% (95% CI 
10.1–16.9), post-traumatic stress disorder 10.8% (95% CI 7.3–
14.9), specific phobia 10.8% (95% CI 8.2–13.7), obsessive 
compulsive disorder 10.7% (95% CI 8.7–13.0) and agoraphobia 
7.8% (95% CI 5.2–11.0). The lifetime prevalence of any 
anxiety disorders in bipolar was 42.7%. 
Large studies investigating multiple risk factors 
Tsuchiya et al 
200313 
Demographic factors, perinatal 
factors, personal background, 
recent stressful life events, family 
dysfunction, parental loss, history 





Suggestive findings have been provided regarding pregnancy 
and obstetric complications, winter–spring birth, stressful life 
events, traumatic brain injuries and multiple sclerosis with a 
later risk for bipolar. However, evidence is still inconclusive. 
Childbirth is likely to be a risk factor. 
Marangoni et al 
201669 
Maternal influenza during 
pregnancy, indicators of foetal 
development, 
cannabis, cocaine, opioids, 
tranquilizers, stimulants, 
sedatives, parental loss, 






Only preliminary evidence exists that exposure to viral 
infection, substances or trauma increase the likelihood of 
bipolar. 
Bortolato 201772 51 environmental risk factors Umbrella 
review 
16 studies Only irritable bowel syndrome emerged as a risk factor for 
bipolar supported by convincing evidence, and childhood 
adversity was supported by highly suggestive evidence. Asthma 
and obesity were risk factors for bipolar supported by 
suggestive evidence, and seropositivity to T.gondii and a 
history of head injury were supported by weak evidence. 
Gilman 201279 Demographic factors, 
characteristics of depression, prior 
Prospective 
cohort 
6,214 cases of 
MDD 
Demographic risk factors for the transition from MDD to 
bipolar included younger age, black race/ethnicity, and less 
than high school education. Clinical characteristics of 
psychopathology, childhood 
trauma 
depression were not associated with diagnostic conversion. 
Prior psychopathology was associated with the transition to 
bipolar: history of social phobia (OR=2.20, 95% CI 1.47–3.30) 
and generalized anxiety disorder (OR=1.58, 95% CI, 1.06–
2.35). Environmental stressors that predicted the transition to 
bipolar include: history of child abuse (OR=1.26, 95% CI 1.12–
1.42) and past-year problems with social support group 
(OR=1.79, 95% CI 1.19–2.68). 
Mortensen et al 
200393 
Family history, urbanicity of birth 
place, season of birth, birth order, 
influenza epidemics during 









Those with a first-degree relative with bipolar had a 13.63-fold 
increased risk (95% CI 11.81-15.71). Children who experienced 
maternal loss before their fifth birthday had a 4.05 (95% CI 
1.68-9.77) increased risk of bipolar. No other consistent 
associations were found.  
Abbreviations: Bipolar – bipolar disorder, MDD – major depressive disorder, OR – odds ratio, CI – confidence interval, HR – hazard ratio, SNP – single 
nucleotide polymorphism, COMT – Catechol-O-methyltransferase, MS – multiple sclerosis, ADHD – attention deficit hyperactivity disorder 
 
